Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
Biomarker
|
disease |
BEFREE |
PTEN is a tumor suppressor gene mutated in many human sporadic cancers and in hereditary cancer syndromes such as Cowden disease, Bannayan-Zonana syndrome and Lhermitte-Duclos disease.
|
12655146 |
2003 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
PTEN, encoding a dual phosphatase tumor suppressor, is mutated in 85 and 65% of individuals with Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndrome (BRRS), respectively.
|
16014636 |
2005 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
PTEN somatic mutations occur in sporadic tumors of the endometrium, brain, prostate, or melanomas, while germline mutations predispose to development of the multiple hamartoma syndromes (i.e., Cowden's disease and Bannayan-Zonana syndrome).
|
16487009 |
2006 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
Biomarker
|
disease |
BEFREE |
PTEN, originally linked to Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome, has also been associated with JPS.
|
18178612 |
2008 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
Biomarker
|
disease |
BEFREE |
Phosphatase and tensin homolog (PTEN) hamartoma tumor syndrome (PHTS) encompasses several rare disorders linked to mutations of the PTEN gene, including Cowden disease (CD) and Bannayan-Riley-Ruvalcaba syndrome (BRRS).
|
25170002 |
2014 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Additionally, germ-line mutations of PTEN/MMAC1 are responsible for several familial neoplastic disorders, including Cowden disease and Bannayan-Zonana syndrome.
|
9354433 |
1997 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Approximately, 10% of CS-related PTEN mutations occur in the PTEN promoter and 11% of BRRS-related mutations include large deletions, often favoring the gene's 5' end (exon 1, promoter).
|
17341483 |
2007 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
As PTEN is a dual phosphatase mutated in autosomal inherited disorders with phenotypes similar to those of PJS (Bannayan-Riley-Ruvalcaba syndrome and Cowden disease), our study suggests a functional link between the proteins involved in different hamartomatous polyposis syndromes and emphasizes the central role played by LKB1 as a tumor suppressor in the small intestine.
|
15987703 |
2005 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Assessment of PTEN-associated vascular malformations in a patient with Bannayan-Riley-Ruvalcaba syndrome.
|
27358095 |
2016 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
Biomarker
|
disease |
CTD_human |
Bannayan-Riley-Ruvalcaba syndrome: a cause of extreme macrocephaly and neurodevelopmental delay.
|
19321504 |
2009 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
Biomarker
|
disease |
CTD_human |
Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers.
|
17526800 |
2007 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers.
|
17526800 |
2007 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Cowden's disease (CD) and Bannayan-Ruvalcaba-Riley syndrome (BRRS) are allelic disorders characterized by multiple hamartomatous overgrowths of the thyroid, breast, skin, and gastrointestinal tract, and an increased risk of developing benign and malignant tumors of the breast and thyroid gland, secondary to germline point mutations in the PTEN gene.
|
15067177 |
2004 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease.
|
9286463 |
1997 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
Biomarker
|
disease |
CTD_human |
Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease.
|
9286463 |
1997 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, we review the PTEN mutation positive BRRS cases, to further delineate the phenotype and to compare the cases with a genomic deletion with the cases with a point mutation.
|
14574156 |
2003 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
Biomarker
|
disease |
CTD_human |
Furthermore, we review the PTEN mutation positive BRRS cases, to further delineate the phenotype and to compare the cases with a genomic deletion with the cases with a point mutation.
|
14574156 |
2003 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
Biomarker
|
disease |
CTD_human |
Genital lentigines in a 6-year-old boy with a family history of Cowden's disease: clinical and genetic evidence of the linkage between Bannayan-Riley-Ruvacalba syndrome and Cowden's disease.
|
11685670 |
2001 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
Biomarker
|
disease |
CTD_human |
Genotype-phenotype analyses within the BRR group suggested a number of correlations, including the association of PTEN mutation and cancer or breast fibroadenoma in any given CS, BRR or BRR/CS overlap family ( P = 0.014), and, in particular, truncating mutations were associated with the presence of cancer and breast fibroadenoma in a given family ( P = 0.024).
|
10400993 |
1999 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Genotype-phenotype analyses within the BRR group suggested a number of correlations, including the association of PTEN mutation and cancer or breast fibroadenoma in any given CS, BRR or BRR/CS overlap family ( P = 0.014), and, in particular, truncating mutations were associated with the presence of cancer and breast fibroadenoma in a given family ( P = 0.024).
|
10400993 |
1999 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Germ-line mutations of phosphatase and tensin homolog, deleted on chromosome ten (PTEN) are found in two inherited hamartoma tumor syndromes: Cowden syndrome, which has a high risk of breast, thyroid, and other cancers; and Bannayan-Zonana syndrome, a related disorder.
|
10582703 |
1999 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Germline PTEN mutations cause Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndrome (BRR), two hamartoma-tumour syndromes, and somatic PTEN alterations have been shown to participate, to a greater or lesser extent, in a wide variety of sporadic neoplasia.
|
10749983 |
2000 |
Bannayan-Riley-Ruvalcaba Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Germline PTEN mutations cause Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndrome (BRR), two hamartoma-tumor syndromes with an increased risk of breast, thyroid and endometrial cancers.
|
11854177 |
2002 |